IRIS UniCatt

Scatena, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.208
EU - Europa 2.834
AS - Asia 2.389
SA - Sud America 445
AF - Africa 61
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.947
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.112
SG - Singapore 978
CN - Cina 697
DE - Germania 616
RU - Federazione Russa 537
SE - Svezia 369
BR - Brasile 351
UA - Ucraina 319
FR - Francia 188
VN - Vietnam 186
IT - Italia 167
PL - Polonia 154
GB - Regno Unito 121
IE - Irlanda 118
TR - Turchia 105
FI - Finlandia 97
IN - India 92
ID - Indonesia 79
JP - Giappone 56
CA - Canada 54
BD - Bangladesh 38
HK - Hong Kong 32
AR - Argentina 28
ES - Italia 26
IQ - Iraq 25
BE - Belgio 23
MX - Messico 21
NL - Olanda 21
KR - Corea 19
VE - Venezuela 17
ZA - Sudafrica 16
MA - Marocco 14
CO - Colombia 11
EC - Ecuador 11
PK - Pakistan 11
RO - Romania 10
AT - Austria 8
CH - Svizzera 8
CZ - Repubblica Ceca 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
IL - Israele 7
IR - Iran 7
UZ - Uzbekistan 7
KE - Kenya 6
PT - Portogallo 6
PY - Paraguay 6
AU - Australia 5
BY - Bielorussia 5
EG - Egitto 5
MY - Malesia 5
PE - Perù 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
UY - Uruguay 5
AL - Albania 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
LT - Lituania 4
DK - Danimarca 3
GR - Grecia 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
NG - Nigeria 3
NP - Nepal 3
PH - Filippine 3
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GN - Guinea 1
KG - Kirghizistan 1
KH - Cambogia 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
Totale 8.935
Salva come PNG Salva come JPEG
Città #
Singapore 498
Chandler 406
Ashburn 378
San Jose 246
Jacksonville 157
Warsaw 150
Beijing 123
San Mateo 116
Dublin 113
Nanjing 106
New York 89
Wilmington 84
The Dalles 72
Woodbridge 69
Ann Arbor 68
Houston 66
Los Angeles 66
Jakarta 65
Izmir 62
Lauterbourg 60
Fairfield 58
Hefei 58
Dearborn 57
Ho Chi Minh City 52
Boston 49
Hanoi 46
Lawrence 45
Seattle 44
Tokyo 44
Redmond 43
Cattolica 37
Chicago 37
São Paulo 34
Moscow 33
Frankfurt am Main 32
Hong Kong 29
Helsinki 28
Bremen 27
Mountain View 25
Shanghai 25
Cambridge 23
Kunming 23
Redwood City 23
Montreal 21
Munich 21
Boardman 20
Nürnberg 20
Zhengzhou 20
Kent 19
Detroit 18
Milan 18
Nanchang 18
Princeton 18
Hangzhou 17
Shenyang 17
London 16
Rome 16
Brussels 15
Hebei 15
Dallas 14
Guangzhou 14
Lancaster 13
Toronto 13
University Park 13
Marseille 12
Philadelphia 12
Pune 12
Santa Clara 12
Brooklyn 11
Buffalo 11
Jiaxing 11
Seoul 11
Changsha 10
Johannesburg 10
Orem 10
Baghdad 9
Belo Horizonte 9
Dhaka 9
Paris 9
Tianjin 9
Turku 9
Atlanta 8
Edinburgh 8
Cardiff 7
Da Nang 7
Düsseldorf 7
Haiphong 7
Lanzhou 7
Simi Valley 7
Tashkent 7
Chengdu 6
Chennai 6
Curitiba 6
Indiana 6
Istanbul 6
Madrid 6
Manchester 6
Norwalk 6
Phoenix 6
Renton 6
Totale 4.523
Salva come PNG Salva come JPEG
Nome #
FUNCTIONAL ALTERATIONS IN ADULT AND FETAL HEMOGLOBIN SASSARI ASP-ALPHA-126(H9) -] HIS - THE ROLE OF ALPHA(1)ALPHA(2) CONTACT 603
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing 401
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects 204
CA 19-9: Biochemical and Clinical Aspects 195
Advances in Cancer Biomarkers - From biochemistry to clinic for a critical revision 194
Advances in Cancer Stem Cell Biology 191
MITOCHONDRIAL DAMAGE AND METABOLIC COMPENSATORY MECHANISMS INDUCED BY HYPEROXIA IN U-937 CELL LINE. 186
A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell line 183
Neuron Specific Enolase as a biomarker: biochemical and clinical aspects 183
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 3. Discovery of Novel Lead Compounds Through Structure-Based Drug Design and Docking Studies 182
Mitochondrial proteomic approaches for new potential diagnostic and prognostic biomarkers in cancer 175
Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology. 169
Prognostic value of the reactive oxygen species in severe sepsis and septic shock patients: a-pilot study 168
Derangement of erythrocytic AE1 in beta-thalassemia by caspase 3: pathogenic mechanisms and implications in red blood cell senescence 163
A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists. 161
Advances in Mitochondrial Medicine 160
A Critical Approach to Clinical Biochemistry of Chromogranin A 159
An update on pharmacological approaches to neurodegenerative diseases. 157
The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects 156
Circulating tumour cells and cancer stem cells: A role for proteomics in defining the interrelationships between function,phenotype and differentiation with potential clinical applications. 153
The epithelial–mesenchymal transition in cancer: a potential critical topic for translational proteomic research 151
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 2. Effect of Pyrrole C2 and/or C4 Substitutions on Biological Activity 150
Bezafibrate Induces a Mitochondrial Derangement in Human Cell Lines. Intriguing Effects for a Peroxisome Proliferator. 150
Immunological role of IgG subclasses 150
CA 19-9: Biochemical and Clinical Aspects 147
Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy 144
The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. 136
Oxygen transport by Fetal Bovine Hemoglobin 134
The proteomics of cancer stem cells. Potential clinical applications for innovative research in oncology 133
Modulation of cancer cell line differentiation: A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis, and therapy of cancer. 131
Cancer stem cells: the development of new cancer therapeutics 130
Cancer Stem Cells: An Innovative Therapeutic Approach 128
Immunological role of IgG subclasses 127
Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications 125
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential. 125
Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. 123
The role of CA 125 as tumor marker: biochemical and clinical aspects 122
A critical approach to clinical biochemistry of Chromogranin A 122
CA 19-9: Biochemical and Clinical Aspects 120
Cancer Biomarkers: A Status Quo 119
Cancer Stem Cells: Proteomic Approaches for New Potential Diagnostic and Prognostic Biomarkers 113
Advances in Heat Shock Proteomics: Towards a Better Understanding of the Physiology and Pathophysiology of Molecular Chaperones. 113
EFFECTS OF GEMFIBROZIL ON THE OXYGEN-TRANSPORT PROPERTIES OF ERYTHROCYTES 113
Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation growth inhibition and terminal cell differentiation 109
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative 108
Glycolytic enzyme inhibitors in cancer treatment. 105
Resveratrol treatment induces redox stress in red blood cells: a possible role of caspase 3 in metabolism and anion transport 105
Cancer Stem Cells: A Revisitation of the “Anaplasia” Concept. In Advances in Cancer Stem Cell Biology 102
SEPARATION OF REDUCED AND OXIDIZED GLUTATHIONE BY MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY 102
Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamates. 100
Glycated human hemoglobin (HbA1c): functional characteristics and molecular modeling studies 100
THE MULTIPLE FUNCTIONS OF HEMOGLOBIN 98
Mitochondrial respiration and differentiation 98
PHYSIOLOGICAL RELEVANCE OF THE OVERALL DELTA-H OF OXYGEN BINDING TO FETAL HUMAN HEMOGLOBIN 94
Aroyl-Pyrrolyl Hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetilase inhibition 93
Cellular respiration and dedifferentiation 90
Mitochondria and drugs 90
The plasma membrane of erythrocytes plays a fundamental role in the transport of oxygen, carbon dioxide and nitric oxide and in the maintenance of the reduced state of the heme iron. 90
Mitochondria and cancer: a growing role in apoptosis, cancer cell metabolism and dedifferentiation 83
Cytotoxicity of a new endodontic filling material 81
Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition. 79
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key? 76
Nitroflurbiprofen (NicOx). 67
Totale 9.019
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.436
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 18 97 14
2021/2022567 48 69 9 59 32 24 14 91 17 26 73 105
2022/20231.663 154 191 94 169 94 137 29 118 583 26 52 16
2023/2024458 25 142 5 12 19 75 16 22 5 23 63 51
2024/20251.120 34 25 85 35 98 43 33 74 156 138 189 210
2025/20262.586 421 103 171 279 406 189 531 151 202 133 0 0
Totale 9.019